Others titles

  • What is an ACO?
  • Assessment of ACO Healthcare Quality Performance for 2016 to 2017
  • Medicare ACO Quality Performance for 2016 and 2017
  • 34 Quality Measures to Assess Healthcare ACO 2016 and 2017
  • ACO 34 Measures to Assess Quality Performance for 2016 and 2017
  • ACO Quality Measure Benchmarks for Reporting for 2016 and 2017

Keywords

  • Medicare Shared Savings Program
  • ACO
  • ACO Healthcare
  • Accountable Care
  • Medicare ACO
  • Healthcare ACO
  • Shared Savings Program
  • ACO 34 Measures
  • Medicare PQRS
  • PQRS Medicare

ACO Quality Measure Benchmark for Reporting Year 2016 and 2017

This dataset describes methods for calculating the quality performance benchmarks for Accountable Care Organizations (ACOs) that are participating in the Medicare Shared Savings Program (Shared Savings Program) and presents the benchmarks for the 34 quality measures for the 2016 and 2017 quality reporting years.

Log in to download
Complexity

Get The Data

For getting access to data download links please read and accept the end-user license agreement.
Your Data License
  • Research
    Non-Commercial, Share-Alike, Attribution Free Forever
  • Commercial
    Commercial Use, Remix & Adapt, White Label Log in to download

John Snow Labs Standard End User License Agreement

Last updated:January 20, 2021

This Data Library End User License Agreement (“EULA”) applies to academic researchers, educators, and students using any product of John Snow Labs in John Snow Labs’ Data Library as defined below (hereinafter referred to “you”). This EULA is between you and John Snow Labs Inc., a Delaware corporation (“John Snow Labs”, “we” or “us”).

By downloading and/or using (as applicable) Data Library of John Snow Labs (as defined below), you automatically agree to be bound by, and use it in compliance with, this EULA. This EULA, together with additional terms and conditions and/or policies referenced herein or located on https://www.johnsnowlabs.com and/or conveyed to you by John Snow Labs, is a legally binding contract between you and John Snow Labs.

PLEASE READ THIS EULA CAREFULLY BEFORE DOWNLOADING OR USING DATA LIBRARY.

We may make changes to this EULA from time to time. When we do so, we will revise the “last updated” date given above. The then-current version of this EULA will supersede all earlier versions. You agree that your continued use of Data Library after such changes have been published to our EULA will constitute your acceptance of such revised EULA.

Definitions

“Data Library” means a data library provided by John Snow Labs and located at https://www.johnsnowlabs.com/marketplace/;

“Website” means https://www.johnsnowlabs.com being owned and operated by John Snow Labs.

Important Notice

By downloading and using any product from the Data Library, you acknowledge that the use of Data Library can be subject to the restrictions and controls imposed by United States export regulations.

You represent and warrant that you do not intend to use Data Library for any purpose prohibited by United States export regulations, including, without limitation, terrorism, cyber-attacks, cyber-crimes, money-laundering, industrial espionage, or nuclear, chemical or biological weapons proliferation. Further, you represent and warrant that you are not listed as a denied party on any list governing United States exports.

Eligibility

Our Data Library can be used by an individual.

In the event you have entered into a separate written agreement with John Snow Labs regarding Data Library that contemplates terms that are inconsistent with this EULA, the written agreement shall control and this EULA will not apply to you to the extent inconsistent with such written agreement, or, if such written agreement is contemplated to be in lieu of this EULA, then this EULA shall not apply at all

License Granted

Subject to your compliance with this EULA, as well as any other applicable policies, John Snow Labs grants you non-exclusive, non-transferable, revocable, license to download, access to, modify, and use of, Data Library worldwide (subject to applicable export laws) during the term of this EULA (as described below) under the following conditions:

  • The license can be used solely for research, private study and personal use of Data Library for unlimited period, or unless terminated under this EULA.were made;
  • This license is personal to you and is limited by all terms and conditions set forth in this EULA;
  • The license is granted as a non-commercial, attribution, share-alike and no-derivate-work license as more detailed below;
  • Under the attribution license, you must give the appropriate name of the creator and a copyright notice of John Snow Labs, provide link to this license and indicate if changes
  • Under the share-alike license, you can distribute modified works only under a license identical to this EULA;
  • Under the no-derivate-work license, you can perform only verbatim copies of Data Library, not derivate works or remixes based on it;
  • If the license is used for academic research purpose, the publication shall be made under the open-access, open-source and open-data license.

You can download any dataset from the Data Library from the Website.

Except for your pre-existing rights and this license granted to you, we and our licensors retain all rights, titles and interests in and to our Data Library, all related intellectual property rights, including trademarks (whether registered or pending), domain and business names. Our Data Library is protected by applicable intellectual property laws, including United States copyright law and international treaties.

John Snow Labs is entitled to revoke the license granted at any time at its sole discretion.

License Restrictions

You will be deemed to have taken any action that you permit, assist or facilitate any person or entity to take related to this EULA, your content or use of Data Library. You are responsible for end users’ use of your content and Data Library. You will ensure that all end users comply with your obligations under this EULA and that the terms of your agreement with each end user are consistent with this EULA. If you become aware of any violation of your obligations under this EULA caused by an end user, you will immediately suspend access to your content and Data Library by such end user.

License Restrictions

You will access or use our Data Library solely via John Snow Labs’ Data Library.

Except as otherwise explicitly provided in this EULA or as may be expressly permitted by applicable law, you will not, and will not permit or authorize any third party to:

  1. you cannot reproduce, translate, enhance, decompile, disassemble, reverse engineer or create derivative works of Data Library or its technological features or measures;
  2. you cannot rent, lease, sell, resell, loan, distribute, or sublicense access to any of Data Library;
  3. you cannot circumvent or disable any security or technological features or measures of Data Library;
  4. you cannot use our intellectual property rights without our express prior written authorization or in violation of this EULA;
  5. you cannot use Data Library with an intent to build a competitive product or service, or copy or substantially copy any ideas, features, functions, organization, structure, application program interface, graphics, or user interface of Data Library;
  6. you cannot copy, distribute, or resell any of the information; audio, visual, and audiovisual works, or other content made available on Data Library (collectively, “Content”) or compile or collect any Content as part of a database or other work;
  7. you cannot use any automated tool (e.g., robots, spiders) to access or use Data Library, or to store, copy, modify, distribute, or resell any Content;
  8. you cannot circumvent or disable any rights management, usage rules, or other security features of Data Library;
  9. you cannot use Data Library in a manner that overburdens, or that threatens the integrity, performance, or availability of, Data Library; or
  10. you cannot remove, alter, or obscure any proprietary notices (including copyright and trademark notices) on any portion of Data Library or any Content.

If you breach any of this EULA, the above license will terminate automatically.

Fees and Taxes

This license is for non-commercial use. If you wish to use our Data Library for commercial use, please contact us at support@JohnSnowLabs.com.

Support and Updates

Under this EULA, support services are excluded.

From time to time John Snow Labs can perform updates to our software. If available, such updates may include bug fixes, new features and/or enhancements. You are solely responsible for deploying such updates at your own risk and liability.

Term and Termination

This EULA will become effective as of the date of your order of Data Library and shall be in effect until terminated.

John Snow Labs may suspend or terminate your right to use Data Library, if you or your end user’s use of Data Library:

  1. is in breach of this EULA;
  2. poses a security risk to Data Library;
  3. could adversely impact our systems, Data Library or other customers;
  4. could subject us, our affiliates, or any third party to liability; or
  5. could be fraudulent.

We may also suspend or terminate your right to use Data Library, if you have ceased to operate in the ordinary course, made an assignment for the benefit of creditors or similar disposition of your assets, or become the subject of any bankruptcy, reorganization, liquidation, dissolution or similar proceeding.

You will cease use of Data Library during any period of suspension, or upon termination of this EULA.

All provisions which by their nature are intended to survive termination shall survive termination of this EULA.

Access to Data Library

We do not provide you with the equipment to access Data Library. You are responsible for all fees charged by third parties related to your access and use of Data Library (e.g., charges by Internet service providers).

You are responsible for monitoring your use of Data Library, including payment of all fees and/or taxes related to such access and use. You agree that John Snow Labs is permitted to request and you hereby consent to provide John Snow Labs information related to your use of Data Library for auditing purposes.

You also certify that you are legally permitted to use Data Library, and take full responsibility for the selection and use of Data Library. This EULA is void where prohibited by law, and the right to use Data Library is revoked in such jurisdictions. John Snow Labs makes no claim that Data Library may be lawfully used outside of the United States. If you use Data Library from outside of the United States, you do so at your own risk and you are responsible for compliance with the laws of jurisdiction.

Privacy Policy

We may collect, store and receive personal and other information about you through our Products. Our collection and use of this information is governed by our Privacy Policy available at https://www.JohnSnowLabs.com/privacy/ which may be amended from time to time.

Links and Third Party Content

Data Library may display, or contain links to, third party products, services, and websites. Any opinions, advice, statements, services, offers, or other information that constitutes part of the content expressed, authored, or made available by other users or other third parties, or which is accessible through or may be located using Data Library (collectively, “Third Party Content”) are those of the respective authors or producers and not of us or our shareholders, directors, officers, employees, agents, or representatives.

We do not control Third Party Content and do not guarantee the accuracy, integrity or quality of such Third Party Content. We are not responsible for the performance of, we do not endorse, and we are not responsible or liable for, any Third Party Content or any information or materials advertised in any Third Party Content. By using Data Library, you may be exposed to content that is offensive, indecent, or objectionable. We are not responsible or liable, directly or indirectly, for any damage or loss caused to you by your use of or reliance on any goods, services, or information available on or through any third party service or Third Party Content. It is your responsibility to evaluate the information, opinion, advice, or other content available on and through our Products.

Proprietary Rights

John Snow Labs will not obtain any rights under this EULA from you (or your licensors) to your content.

Data Library is and remains the exclusive property of John Snow Labs and its licensors. Except for the access and use rights expressly set forth in this EULA, no license or other rights in or to Data Library or John Snow Labs trademark(s) and other intellectual property rights therein, are granted to you, and all such licenses and rights are expressly reserved. You will not remove, alter, or obscure any proprietary notices (including copyright and trademark notices) on any portion of Data Library or any Content.

Trademarks

“John Snow Labs,” the John Snow Labs logo, and any other product, business or service name or slogan, whether registered or pending, displayed on Data Library are trademarks of John Snow Labs, Inc. or its suppliers or licensors, and may not be copied, imitated or used, in whole or in part, without the prior written permission of John Snow Labs or the applicable trademark holder. You may not use any metatags or any other “hidden text” utilizing “John Snow Labs” or any other name, trademark or product, business or service name of John Snow Labs without our prior written permission. In addition, the look and feel of Data Library, including all page headers, custom graphics, button icons and scripts, is the service mark, trademark and/or trade dress of John Snow Labs may not be copied, imitated or used, in whole or in part, without our prior written permission. All other trademarks, pending trademarks, registered trademarks, product names and company names or logos mentioned in Data Library are the property of John Snow Labs Inc. and/or their respective owners. Reference to any products, services, processes or other information, by trade name, trademark, manufacturer, supplier, or otherwise does not constitute or imply endorsement, sponsorship, or recommendation thereof by us.

Disclaimer of Warranties

YOUR USE OF DATA LIBRARY IS AT YOUR SOLE RISK. THE PRODUCTS AND CONTENT EACH ARE PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS. WE AND OUR SUPPLIERS AND LICENSORS EXPRESSLY DISCLAIM ALL WARRANTIES OF ANY KIND, WHETHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, AND NON-INFRINGEMENT. WE DO NOT GUARANTEE THE ACCURACY, COMPLETENESS, OR USEFULNESS OF THE PRODUCTS OR ANY CONTENT, AND YOU RELY ON THE PRODUCTS AND CONTENT AT YOUR OWN RISK. ANY MATERIAL THAT YOU ACCESS OR OBTAIN THROUGH OUR PRODUCTS IS DONE AT YOUR OWN DISCRETION AND RISK AND YOU WILL BE SOLELY RESPONSIBLE FOR ANY DAMAGE TO YOUR COMPUTER OR LOSS OF DATA THAT RESULTS FROM THE DOWNLOAD OF ANY MATERIAL THROUGH OUR PRODUCTS. NO ADVICE OR INFORMATION, WHETHER ORAL OR WRITTEN, OBTAINED BY YOU FROM US OR THROUGH OR FROM OUR PRODUCTS WILL CREATE ANY WARRANTY NOT EXPRESSLY STATED IN THIS EULA. SOME STATES MAY PROHIBIT A DISCLAIMER OF WARRANTIES AND YOU MAY HAVE OTHER RIGHTS THAT VARY FROM STATE TO STATE.

Limitation of Liability

WE AND OUR SUPPLIERS AND LICENSORS WILL NOT BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR EXEMPLARY DAMAGES, INCLUDING BUT NOT LIMITED TO, DAMAGES FOR LOSS OF PROFITS, GOODWILL, USE, DATA, OR OTHER INTANGIBLE LOSSES (EVEN IF WE HAVE BEEN ADVISED OF THE POSSIBILITY OF THESE DAMAGES), RESULTING FROM YOUR USE OF OUR PRODUCTS AND CONTENT. UNDER NO CIRCUMSTANCES WILL THE TOTAL LIABILITY OF US AND OUR SUPPLIERS AND LICENSORS OF ALL KINDS ARISING OUT OF OR RELATED TO YOUR USE OF THE PRODUCTS AND CONTENT (INCLUDING BUT NOT LIMITED TO WARRANTY CLAIMS), REGARDLESS OF THE FORUM AND REGARDLESS OF WHETHER ANY ACTION OR CLAIM IS BASED ON CONTRACT, TORT, OR OTHERWISE, EXCEED THE AMOUNTS, IF ANY, THAT YOU HAVE PAID FOR YOUR USE OF THE PRODUCTS AND CONTENT. BECAUSE SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF LIABILITY FOR CONSEQUENTIAL OR INCIDENTAL DAMAGES, THE ABOVE LIMITATION MAY NOT APPLY TO YOU.

Indemnity

To the full extent permitted by applicable law, you shall defend, indemnify and hold harmless John Snow Labs, its affiliates and its licensors, and each of their respective employees, officers, directors, and representatives from and against any claims, damages, losses, liabilities, costs, and expenses (including reasonable attorney’s fees) arising out of or relating to any third party claim concerning: (a) your use of Data Library; (b) breach of this EULA or violation of applicable law by you; (c) any content or the combination of such content with other software, content or processes, including any claim involving alleged infringement or misappropriation of third-party rights by such content or combination; or (d) breach of any obligation or duty you owe to a third party.

Legal Notices

Enforcement of this EULA will be governed by the laws of the State of Delaware, excluding its conflict and choice of law principles. The exclusive jurisdiction and venue for any claims arising out of or related to this EULA or your use of Data Library will lie in the state and federal courts located in Sussex County, within the State of Delaware, and you irrevocably agree to submit to the jurisdiction of such courts. Our failure to enforce any right or provision in this EULA will not constitute a waiver of such right or provision unless acknowledged and agreed by us in writing. In the event that a court of competent jurisdiction finds any provision of this EULA to be illegal, invalid, or unenforceable, the remaining provisions will remain in full force and effect.

Notifications

We may use your contact information to notify you if we have any legitimate interest or if we need to notify you on any important information related to your use of Data Library. We will not send you newsletters unless you expressly consented to such notifications.

Contacting Us

If you have any questions or concerns about Data Library or this EULA, you may contact us by email at support@JohnSnowLabs.com.

Description

ACOs are required to completely and accurately report quality data that are used to calculate and assess their quality performance. In addition, in order to be eligible to share in any savings generated, an ACO must meet the established quality performance standard that corresponds to its performance year. This document also reviews the quality performance benchmarks and scoring methodology, as described in the Shared Savings Program regulations. Enrichments have also been made to include appropriate ICD10 and HCPCS codes for each ACO measure.

In the first performance year of their first agreement period, ACOs satisfy the quality performance standard when they completely and accurately report on all quality measures (pay-for-reporting). Complete and accurate reporting in the ACO’s first performance year qualifies the ACO for the maximum sharing rate. In subsequent performance years, quality performance benchmarks are phased-in for performance measures and the quality performance standard requires ACOs to continue to completely and accurately report quality data on all measures but the ACOs final sharing rate is determined based on its performance compared to national benchmarks.

In addition, ACOs must meet minimum attainment (30th percentile benchmark) on at least 1 pay-for-performance measure in each domain in order to be eligible to share in savings. Both attainment and improvement in performance are taken into account when calculating the final sharing rate for ACOs in their second and subsequent performance years. ACOs are rewarded up to four additional points in each domain, if they demonstrate quality improvement. In this way, the ACO becomes increasingly responsible for quality performance and improvement during the first agreement period. When an ACO renews its participation in the program for a second or subsequent agreement period, the quality performance of ACOs is assessed in the same manner as ACOs in the third performance year of their first agreement period.

Quality performance benchmarks are established by the Centers for Medicare and Medicaid Services (CMS) prior to the reporting period for which they apply and are set for 2 years. This document defines and sets the quality performance benchmarks that will be used for the 2016 and 2017 reporting periods. These benchmarks will apply to all Shared Savings Program ACOs reporting quality data in 2016 and 2017.

For the 2016 reporting year, CMS will measure quality of care using 34 quality measures (32 individual measures and 1 composite measure that include 2 individual component measures). The quality measures span four quality domains: Patient/Caregiver Experience, Care Coordination/Patient Safety, Preventive Health, and At-Risk Population. Because new quality measures introduced to the Shared Savings Program are set at the level of complete and accurate reporting for the first 2 years before phasing into performance, this document will be updated prior to the 2017 reporting year to include benchmarks for 7 measures (including the Diabetes Composite) that phase into performance for the 2017 reporting year. The benchmarks for each measure along with the phase-in schedule for pay-for-performance are displayed in the Table.

It is also important to note that CMS maintains the authority to revert measures from pay-for-performance to pay-for-reporting when the measure owner determines the measure causes patient harm or no longer aligns with clinical practice. Should CMS need to make such a modification, CMS will alert the ACOs through the Spotlight newsletter.

**Benchmark Data Sources**
These 2016 and 2017 benchmarks used all available and applicable 2012, 2013 or 2014 Medicare fee-for-service (FFS) data. This includes:

– Quality data reported through the Physician Quality Reporting System (PQRS) by physicians and groups of physicians through the Web Interface, claims, or a registry for the 2012, 2013, and2014 performance years, as available;
– Quality data reported by Shared Savings Program and Pioneer Model ACOs through the Web Interface for 2012, 2013 or 2014 performance years;
– Quality measure data collected from the Consumer Assessment of Healthcare Providers and Systems (CAHPS) for ACOs, CAHPS for PQRS and Medicare FFS CAHPS surveys administered for the 2012, 2013 or 2014 performance years;

Attestation and meaningful use data collected through the Electronic Health Record (EHR) Incentive Program for 2013 and 2014.

All of the quality measure benchmarks were calculated using ACO, group practice and individual physician data aggregated to the TIN level and included if there were at least 20 cases in the denominator. Quality data for ACOs, providers or group practices that did not satisfy the reporting requirements of the Shared Savings Program or PQRS were not included in calculation of the benchmarks.
Benchmarks for ACO Quality Measures
Benchmarks for the 23 of the 34 quality measures that are pay-for-performance for the 2016 and 2017 reporting years for an ACO’s second or third year of the ACO’s first agreement period are specified in the Table. ACOs in a second agreement period should refer to performance year 3 in the Table. In addition, the following 7 measure benchmarks will be released prior to the 2017 reporting year, because they phase into performance in 2017:

– ACO-34 Stewardship of Patient Resources
– ACO-35 Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)
– ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes
– ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure
– ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions
– ACO-39 Documentation of Current Medications in the Medical Record
– Diabetes Composite (includes 2 component measures)

A quality performance benchmark is the performance rate an ACO must achieve to earn the corresponding quality points for each measure. The Table shows the benchmark for each percentile, starting with the 30th percentile (corresponding to the minimum attainment level) and ending with the 90th percentile (corresponding to the maximum attainment level). Under the Shared Savings Program’s regulation at 42 C.F.R. 425.502, there are circumstances when the set benchmark uses flat percentages. The use of flat percentages addresses issues with measures that have an overall high level of performance and allows ACOs with high scores to be recognized for their performance and earn maximum or near maximum quality points while also recognizing a range of performance levels allowing room for improvement and rewarding that improvement in subsequent years. For 15 measures, benchmarks using flat percentages use the 60th percentile when it is equal to or greater than 80.00 percent. For 3 measures, benchmarks using flat percentages use the 90th percentile when it is equal to or greater than 95.00 percent.

In efforts to maintain consistency across benchmarks, the ACO-10 Ambulatory Sensitive Conditions Admissions were also displayed: Heart Failure observed to expected ratio percentiles as percentages. ACOs can compare their previous annual performance scores for ACO-9 and ACO-10 by multiplying their observed/expected ratio performance rates with the following national means:

– ACO-9 national mean performance rate: 6.86%
– ACO-10 national mean performance rate: 18.19%

**Quality Scoring Points System**
The Table shows the maximum possible points that may be earned by an ACO in each domain and overall. An ACO achieves the maximum points for all measures designated as pay for reporting when the ACO completely and accurately reports. For measures that are pay for performance, quality scoring will be based on the ACO’s level of performance on each measure.
An ACO will earn quality points for each measure on a sliding scale based on level of performance. Performance below the minimum attainment level (the 30th percentile) for a measure will receive zero points for that measure; performance at or above the 90th percentile of the quality performance benchmark earns the maximum points available for the measure.
For most of the measures, the higher the level of performance, the higher the corresponding number of quality points. However, it is important to note that eight ACO quality measures have a reverse scoring structure, which means that a lower score represents better performance, and a higher score represents worse performance.

The following measures are scored such that a lower rate is indicative of better performance:

– ACO-8: Risk Standardized, all condition readmissions.
– ACO-9: Ambulatory Sensitive Conditions Admissions: for COPD or asthma in older adults.
– ACO-10: Ambulatory Sensitive Conditions Admissions: for heart failure (HF).
– ACO-27: Diabetes Mellitus: Hemoglobin A1c poor control.
– ACO-35: Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)
– ACO-36: All-Cause Unplanned Admissions for Patients with Diabetes
– ACO-37: All-Cause Unplanned Admissions for Patients with Heart Failure
– ACO-38: All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions

A maximum of 2 points can be earned for each scored individual or composite measure, except for the Percent of Primary Care Physicians who Successfully Met Meaningful Use Requirements measure (ACO-11). The ACO-11 measure is double weighted and is worth up to 4 points to provide incentive for greater levels of EHR adoption.

The matrix below shows the points earned for each measure at the corresponding decile value. For example, if an ACO’s performance rate for the Influenza immunization measure (ACO-14) is 72 percent or percentile, it would earn 1.70 points for that measure. Because the EHR measure (ACO-11) is double weighted, an ACO’s performance rate of 78 percent or percentile on that measure would earn 3.40 points.

**ACO Performance Level Quality points**
90+ percentile benchmark or 90+ percent 2.00 points
80+ percentile benchmark or 80+ percent 1.85 points
70+ percentile benchmark or 70+ percent 1.70 points
60+ percentile benchmark or 60+ percent 1.55 points
50+ percentile benchmark or 50+ percent 1.40 points
40+ percentile benchmark or 40+ percent 1.25 points
30+ percentile benchmark or 30+ percent 1.10 point
<30 percentile benchmark or <30+ percent No points

**Quality Improvement Reward**
Additionally, CMS will reward ACOs that demonstrate significant improvement in their quality measure performance by adding up to 4.00 points to each domain score. The total points in each domain cannot exceed the maximum points that are possible in that domain. For instance, an ACO may receive 4.00 additional points in the Preventive Health domain by demonstrating quality improvement; however, the ACO’s total points for the domain cannot exceed the maximum 18 possible points that can be earned for the Preventive Health domain.

The total points earned for measures in each domain, including any quality improvement points, will be summed and divided by the total points available for that domain to produce a domain score of the percentage of points earned relative to points available. The percentage score for each domain will be averaged together to generate a final overall quality score for each ACO that will be used to determine the amount of savings it shares or, if applicable, the amount of losses it owes.

About this Dataset

Data Info

Date Created

2016-01-13

Last Modified

2016-07-26

Version

1

Update Frequency

Biennial

Temporal Coverage

2012-2014

Spatial Coverage

United States

Source

John Snow Labs; Centers for Medicare and Medicaid Services (CMS);

Source License URL

Source License Requirements

N/A

Source Citation

N/A

Keywords

Medicare Shared Savings Program, ACO, ACO Healthcare, Accountable Care, Medicare ACO, Healthcare ACO, Shared Savings Program, ACO 34 Measures, Medicare PQRS, PQRS Medicare

Other Titles

What is an ACO?, Assessment of ACO Healthcare Quality Performance for 2016 to 2017, Medicare ACO Quality Performance for 2016 and 2017, 34 Quality Measures to Assess Healthcare ACO 2016 and 2017, ACO 34 Measures to Assess Quality Performance for 2016 and 2017, ACO Quality Measure Benchmarks for Reporting for 2016 and 2017

Data Fields

NameDescriptionTypeConstraints
DomainThe description of the domain or criteria to be assessed for quality measure.string-
ACO_Measure_NumberThe description of the Accountable Care Organization (ACO) number that is used to assess quality measure.stringunique : 1
Measure_DescriptionDetailed description of the domain for quality measurement.string-
ICD10_CodeThe International Classification of Diseases ICD-10 code/codes for a specific ACO measure.string-
ICD10_DescriptionDescription used by physicians and other healthcare providers to classify and code all diagnoses, symptoms and procedures recorded in conjunction with hospital care.string-
HCPCS_CodeThe Healthcare Common Procedure Coding System (HCPCS) code/codes for a specific ACO measure.string-
HCPCS_DescriptionDescription of the Level II of the HCPCS standardized coding system that is used primarily to identify products, supplies, and services not included in the CPT codes, such as ambulance services and durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) when used outside a physician's office.string-
Pay_For_Performance_Phase_Year1The description of the pay for performance quality for Year 1 of the program.string-
Pay_For_Performance_Phase_Year2The description of the pay for performance quality for Year 2 of the program.string-
Pay_For_Performance_Phase_Year3The description of the pay for performance quality for Year 3 of the program.string-
Sliding_Scale_Measure_Score_30_PercentDescription of the fee percentage for a 30 percent sliding scale performance quality measure.numberlevel : Ratio
Sliding_Scale_Measure_Score_40_PercentDescription of the fee percentage for a 40 percent sliding scale performance quality measure.numberlevel : Ratio
Sliding_Scale_Measure_Score_50_PercentDescription of the fee percentage for a 50 percent sliding scale performance quality measure.numberlevel : Ratio
Sliding_Scale_Measure_Score_60_PercentDescription of the fee percentage for a 60 percent sliding scale performance quality measure.numberlevel : Ratio
Sliding_Scale_Measure_Score_70_PercentDescription of the fee percentage for a 70 percent sliding scale performance quality measure.numberlevel : Ratio
Sliding_Scale_Measure_Score_80_PercentDescription of the fee percentage for a 80 percent sliding scale performance quality measure.numberlevel : Ratio
Sliding_Scale_Measure_Score_90_PercentDescription of the fee percentage for a 90 percent sliding scale performance quality measure.numberlevel : Ratio
Better_Performance_MeasureDescription for a better performance measure whether a higher or lower rate is required.string-

Data Preview

DomainACO_Measure_NumberMeasure_DescriptionICD10_CodeICD10_DescriptionHCPCS_CodeHCPCS_DescriptionPay_For_Performance_Phase_Year1Pay_For_Performance_Phase_Year2Pay_For_Performance_Phase_Year3Sliding_Scale_Measure_Score_30_PercentSliding_Scale_Measure_Score_40_PercentSliding_Scale_Measure_Score_50_PercentSliding_Scale_Measure_Score_60_PercentSliding_Scale_Measure_Score_70_PercentSliding_Scale_Measure_Score_80_PercentSliding_Scale_Measure_Score_90_PercentBetter_Performance_Measure
Care Coordination/Patient SafetyACO - 12Medication Reconciliation
At-Risk Population CADACO - 32 Drug Therapy for Lowering LDL Cholesterol
At-Risk Population IVDACO - 29Percent of beneficiaries with IVD with complete lipid profile and LDL control < 100mg/dl
At-Risk Population DiabetesACO - 25Tobacco Non UseZ72.0Tobacco useG9903Pt scrn tbco id as non userReportingReportingPerformance
At-Risk Population DiabetesACO - 26Aspirin UseZ79.82Long term (current) use of aspirinG9277Doc daily aspirin or contraReportingReportingPerformance
Care Coordination/Patient SafetyACO - 39Documentation of Current Medications in the Medical Record*GZ3ZZZZMedication ManagementS9981Medical records copying fee, administrativeReportingPerformancePerformanceHigher Rate
At-Risk Population DiabetesACO - 23Low Density Lipoprotein (LDL) (<100 mg/dL)E78.0, E78.1, E78.00Pure hypercholesterolemia, Pure hyperglyceridemia, Pure hypercholesterolemia, unspecifiedG8039Cad pt w/ldl>100mg/dlReportingReportingPerformance
Care Coordination/Patient SafetyACO - 36All-Cause Unplanned Admissions for Patients with Diabetes*E08Diabetes mellitus due to underlying conditionG8779Diabetes screening test not performed, reason not givenReportingReportingPerformanceLower Rate
At-Risk Population DiabetesACO - 24Blood Pressure (BP) < 140/90Z01.30, Z01.31Encounter for exam of blood pressure w/o abnormal findings, Encounter for exam of blood pressure w abnormal findingsG8478Bp not performed/docReportingReportingPerformance
Patient/Caregiver ExperienceACO - 3CAHPS: Patients' Rating of DoctorZ51Encounter for other aftercare and medical careS0281Medical home program, comprehensive care coordination and planning, maintenance of planReportingPerformancePerformance30405060708090Higher Rate